According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB, Myoglobin, BNP), Application (Myocardial Infarction, ...
In 1990, Bacillus Calmette-Guérin – a vaccine for tuberculosis (TB) – became the first immunotherapy to be approved by the U.S. Food and Drug Administration (FDA ... the plasma – the latter acting as ...
For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...
The FDA granted an orphan drug designation to PEP-010 for the treatment of patients with metastatic pancreatic cancer.
2d
News-Medical.Net on MSNScientists discover irreversible peptide inhibitors for undruggable cancer targetFor the first time scientists have identified promising drug candidates that bind irreversibly with a notoriously "undruggable" cancer protein target, permanently blocking it.
Therapy receives FDA Orphan Drug Designation for PEP-010for treatment of Pancreatic CancerParis (France), March 17, 2025 – ...
6d
News-Medical.Net on MSNBreakthrough peptide inhibitor effective against multiple SARS-CoV-2 variantsSARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.
Dawn Maroney became president of Alignment Health in January at a critical time for the health insurance industry.
Godrej Properties Ltd has purchased ~10 acres of land in Yelahanka, Bengaluru to develop ~1.5 million square feet of saleable area, likely comprising primarily of premium residential development and ...
The Reserve Bank of India has accorded its approval on March 21, 2025 for acquisition of shareholding of up to 100% of the paid-up equity capital of Niwas Housing Finance Pvt Ltd by Witkopeend BV and ...
J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...
Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results